The current PE ratio of VTRS can't be determined, as the TTM EPS of -$0.03 is negative. The last PE ratio of Viatris, recorded in December 2023, was 216.6.
The PE ratio of Viatris has averaged 72.19 over the last ten years. Over the past ten years, VTRS's PE ratio was at its highest in the Dec 2019 quarter at 670, when the stock price was $20.1 and the EPS was $0.03. The lowest value was in the Mar 2023 quarter, when it reached 6.13 with a price of $9.62 and an EPS of $1.57.
Maximum annual increase: 3,227.19% in 2023
Maximum annual decrease: -19.81% in 2017
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 216.6 | 3,227.19% |
| 2022 | 6.51 | N/A |
| 2021 | N/A | N/A |
| 2020 | N/A | N/A |
| 2019 | 670 | 1,587.23% |
| 2018 | 39.71 | 22% |
| 2017 | 32.55 | -19.81% |
| 2016 | 40.59 | 35.12% |
| 2015 | 30.04 | 32.69% |
| 2014 | 22.64 | -14.98% |
| Stock name | PE ratio | Market cap |
|---|---|---|
| OPK Opko Health Inc | N/A | $1.03B |
| OPTN OptiNose Inc | N/A | $125.47M |
| VTRS Viatris Inc | N/A | $14.38B |
The current price to earnings ratio of VTRS can't be calculated, as its EPS of -$0.03 is negative.
As an average over the last 3 years, VTRS stock has a PE ratio of 43.69.
As an average over the last 5 years, VTRS stock has a PE ratio of 109.41.
Over the last ten years, the quarterly PE ratio reached a historic high of 670 in the Dec 2019 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.